ESC 365 - Ferric derisomaltose versus usual care in patients with heart failure, reduced ejection fraction, and iron deficiency: a short-term UK cost-utility analysis based on the IRONMAN RCT

ESC Professional Premium Access

Ferric derisomaltose versus usual care in patients with heart failure, reduced ejection fraction, and iron deficiency: a short-term UK cost-utility analysis based on the IRONMAN RCT

Session: Collateral damage in heart failure: comorbidities and their treatment

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Mr R. Pollock (Harpenden, GB)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Mr Richard Fulton Pollock

Covalence Research Ltd, Harpenden (United Kingdom of Great Britain & Northern Ireland)

0 follower

4 more presentations in this session

Development and validation of a risk prediction model for worsening renal function in patients with incident heart failure

Speaker: Professor C. Lang (Dundee, GB)

Prevalent and incident anemia in PARAGON-HF

Speaker: Doctor H. Lu (Boston, US)

Impact of various iron deficiency definitions on mortality risk in chronic heart failure across the spectrum of left ventricular ejection fraction spectrum.

Speaker: Doctor A. Mohamed (Gentofte, DK)

Non-linear causal effects of kidney function on the risk of heart failure: a Mendelian randomization study

Speaker: Doctor J. Liu (Guangzhou, CN)

Access the full session

Collateral damage in heart failure: comorbidities and their treatment

Speakers: Mr R. Pollock, Professor C. Lang, Doctor H. Lu, Doctor A. Mohamed, Doctor J. Liu

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources